BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15716970)

  • 1. CTL responses to HIV and SIV: wrestling with smoke.
    John M; Mallal S
    Nat Immunol; 2005 Mar; 6(3):232-4. PubMed ID: 15716970
    [No Abstract]   [Full Text] [Related]  

  • 2. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
    Yang OO
    Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV escape: there and back again.
    Altman JD; Feinberg MB
    Nat Med; 2004 Mar; 10(3):229-30. PubMed ID: 14991039
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity.
    Kent SJ; Fernandez CS; Dale CJ; Davenport MP
    Trends Microbiol; 2005 Jun; 13(6):243-6. PubMed ID: 15936652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation.
    Kobayashi M; Igarashi H; Takeda A; Kato M; Matano T
    J Virol; 2005 Sep; 79(17):11529-32. PubMed ID: 16103206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T-cell epitopes in HIV/SIV infection.
    Venet A; Walker BD
    AIDS; 1993; 7 Suppl 1():S117-26. PubMed ID: 7689848
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-HIV adaptive immunity: determinants for viral persistence.
    Yamamoto H; Matano T
    Rev Med Virol; 2008; 18(5):293-303. PubMed ID: 18416450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV/AIDS. HLA leaves its footprints on HIV.
    McMichael A; Klenerman P
    Science; 2002 May; 296(5572):1410-1. PubMed ID: 12029119
    [No Abstract]   [Full Text] [Related]  

  • 9. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants.
    Barouch DH; Powers J; Truitt DM; Kishko MG; Arthur JC; Peyerl FW; Kuroda MJ; Gorgone DA; Lifton MA; Lord CI; Hirsch VM; Montefiori DC; Carville A; Mansfield KG; Kunstman KJ; Wolinsky SM; Letvin NL
    Nat Immunol; 2005 Mar; 6(3):247-52. PubMed ID: 15685174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape.
    Sewell AK; Price DA; Oxenius A; Kelleher AD; Phillips RE
    Stem Cells; 2000; 18(4):230-44. PubMed ID: 10924089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential patterns of immune escape at Tat-specific cytotoxic T cell epitopes in pigtail macaques.
    Mason RD; De Rose R; Kent SJ
    Virology; 2009 Jun; 388(2):315-23. PubMed ID: 19394064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates of HIV immune escape and reversion: implications for vaccination.
    Davenport MP; Loh L; Petravic J; Kent SJ
    Trends Microbiol; 2008 Dec; 16(12):561-6. PubMed ID: 18964018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV pathogenesis: the first cut is the deepest.
    Picker LJ; Watkins DI
    Nat Immunol; 2005 May; 6(5):430-2. PubMed ID: 15843796
    [No Abstract]   [Full Text] [Related]  

  • 14. What's the matter with HIV-directed killer T cells?
    Wick D; Self SG
    J Theor Biol; 2002 Nov; 219(1):19-31. PubMed ID: 12392972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ T-cell subsets: what really counts in preventing HIV disease?
    Mason RD; De Rose R; Kent SJ
    Expert Rev Vaccines; 2008 Mar; 7(2):155-8. PubMed ID: 18324885
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.
    Kawada M; Igarashi H; Takeda A; Tsukamoto T; Yamamoto H; Dohki S; Takiguchi M; Matano T
    J Virol; 2006 Feb; 80(4):1949-58. PubMed ID: 16439550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis in SIV infection.
    Hurtrel B; Petit F; Arnoult D; Müller-Trutwin M; Silvestri G; Estaquier J
    Cell Death Differ; 2005 Aug; 12 Suppl 1():979-90. PubMed ID: 15818408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV CTL escape: at what cost?
    Smith SM
    Retrovirology; 2004 May; 1():8. PubMed ID: 15169568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of molecular beacons for rapid, real-time, quantitative monitoring of cytotoxic T-lymphocyte epitope mutations in simian immunodeficiency virus.
    Peyerl FW; Barouch DH; Bazick HS; Manuel E; Letvin NL
    J Clin Microbiol; 2005 Sep; 43(9):4773-9. PubMed ID: 16145140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantial envelope-specific CD8 T-cell immunity fails to control SIV disease.
    Peut V; Kent SJ
    Virology; 2009 Feb; 384(1):21-7. PubMed ID: 19091370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.